Resultados de Búsqueda
There is insufficient evidence that the use of antimicrobial mouthwashes and nasal sprays protects against infection in healthcare workers treating patients with suspected or confirmed Covid-19 ...
Evidencias COVID-19
Cochrane Library
Covid‐19 infection poses a serious risk to patients and, due to its contagious nature, to healthcare workers treating them. Irrigating the mouth and nose of healthcare professionals who treat them with antimicrobial solutions could be a method to reduce the risk of infection to healthcare providers. However, the use of these antimicrobial solutions may be associated with damage related to the toxicity of the solutions themselves or to alterations in the natural microbial flora of the mouth or ...
ver más ... 2020The use of Favipiravir as a treatment in patients hospitalized for COVID-19 is not recommended.
Evidencias COVID-19
Epistemonikos Foundation
The available evidence on favipiravir for the treatment of COVID-19 is of very low certainty. It is not possible to establish if it is an effective medicine for this disease. There are numerous ongoing studies, including randomized and nonrandomized clinical trials, that advise against its use. However, in selected seriously ill patients it could be weakly recommended.
ver más ... 2020There is insufficient evidence that the use of antimicrobial mouthwashes and nasal sprays in COVID-19 patients improves patient outcomes or protects healthcare workers treating them from Sars-CoV-2 ...
Evidencias COVID-19
Cochrane Library
Covid‐19 infection poses a serious risk to patients and, due to its contagious nature, to healthcare workers treating them. Irrigating the mouth and nose of these patients with antimicrobial solutions could be a method to reduce the risk of transmission of a possible infection to health workers. However, the use of these antimicrobial solutions may be associated with damage related to the toxicity of the solutions themselves or to alterations in the natural microbial flora of the mouth or ...
ver más ... 2020The use of favipiravir is recommended in the treatment of patients hospitalized for moderate forms of COVID-19 and without risk factors.
Evidencias COVID-19
Fundación Cardioinfantil
Quality of evidence: very low. This recommendation based on new studies could vary. Regarding safety, the results in various studies were not consistent. In the study by Chen et al. (9) The composite rate of elevated aminotransferases, increased serum uric acid, psychiatric symptoms, and gastrointestinal symptoms were higher in the favipiravir group compared to the control group (32 vs 23.3%, RR 1.37, 95% CI 0.90-2.08). In contrast, Cai et al. (11) reported a lower rate of adverse events for ...
ver más ... 2020There is insufficient evidence that the use of antimicrobial mouthwashes and nasal sprays in apparently healthy patients undergoing aerosol-generating procedures can protect healthcare workers from ...
Evidencias COVID-19
Cochrane Library
Covid‐19 infection poses a serious risk to patients and, due to its contagious nature, to healthcare workers treating them. The risks of infection transmission are higher when a patient undergoes an aerosol-generating procedure. Not everyone who has covid-19 is symptomatic, or suspected of being infected. Irrigating the mouth and nose of the patients in question with antimicrobial solutions could be a method to reduce the risk of transmission of a possible hidden infection to health workers. ...
ver más ... 2020